PFE logo

Pfizer Inc. (PFE) Revenue

Annual revenue:

$63.63B+$4.07B(+6.84%)
December 31, 2024

Summary

  • As of today (August 22, 2025), PFE annual revenue is $63.63 billion, with the most recent change of +$4.07 billion (+6.84%) on December 31, 2024.
  • During the last 3 years, PFE annual revenue has fallen by -$17.66 billion (-21.73%).
  • PFE annual revenue is now -36.58% below its all-time high of $100.33 billion, reached on December 31, 2022.

Performance

PFE Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

Quarterly revenue:

$14.65B+$938.00M(+6.84%)
June 29, 2025

Summary

  • As of today (August 22, 2025), PFE quarterly revenue is $14.65 billion, with the most recent change of +$938.00 million (+6.84%) on June 29, 2025.
  • Over the past year, PFE quarterly revenue has increased by +$1.37 billion (+10.31%).
  • PFE quarterly revenue is now -47.18% below its all-time high of $27.74 billion, reached on June 1, 2022.

Performance

PFE Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

TTM revenue:

$63.83B+$1.37B(+2.19%)
June 29, 2025

Summary

  • As of today (August 22, 2025), PFE TTM revenue is $63.83 billion, with the most recent change of +$1.37 billion (+2.19%) on June 29, 2025.
  • Over the past year, PFE TTM revenue has increased by +$7.61 billion (+13.54%).
  • PFE TTM revenue is now -36.97% below its all-time high of $101.28 billion, reached on June 1, 2022.

Performance

PFE TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

PFE Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.8%+10.3%+13.5%
3 y3 years-21.7%-47.2%-37.0%
5 y5 years+54.5%+48.5%+40.9%

PFE Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-36.6%+6.8%-47.2%+12.7%-37.0%+14.1%
5 y5-year-36.6%+54.5%-47.2%+48.5%-37.0%+52.5%
alltimeall time-36.6%+2000.4%-47.2%+1493.1%-37.0%+6839.9%

PFE Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$14.65B(+6.8%)
$63.83B(+2.2%)
Mar 2025
-
$13.71B(-22.8%)
$62.46B(-1.8%)
Dec 2024
$63.63B(+6.8%)
$17.76B(+0.3%)
$63.63B(+5.3%)
Sep 2024
-
$17.70B(+33.3%)
$60.43B(+7.5%)
Jun 2024
-
$13.28B(-10.7%)
$56.22B(+0.5%)
Mar 2024
-
$14.88B(+2.1%)
$55.95B(-6.1%)
Dec 2023
$59.55B(-40.6%)
$14.57B(+8.0%)
$59.55B(-14.0%)
Sep 2023
-
$13.49B(+3.7%)
$69.27B(-11.7%)
Jun 2023
-
$13.01B(-29.6%)
$78.42B(-15.8%)
Mar 2023
-
$18.49B(-23.9%)
$93.16B(-7.2%)
Dec 2022
$100.33B(+23.4%)
$24.29B(+7.3%)
$100.33B(+0.5%)
Sep 2022
-
$22.64B(-18.4%)
$99.88B(-1.4%)
Jun 2022
-
$27.74B(+8.1%)
$101.28B(+9.6%)
Mar 2022
-
$25.66B(+7.6%)
$92.43B(+13.7%)
Dec 2021
$81.29B(+95.2%)
$23.84B(-0.8%)
$81.29B(+17.7%)
Sep 2021
-
$24.04B(+27.2%)
$69.08B(+24.9%)
Jun 2021
-
$18.90B(+30.2%)
$55.33B(+19.5%)
Mar 2021
-
$14.52B(+24.8%)
$46.29B(+10.6%)
Dec 2020
$41.65B(+1.2%)
$11.63B(+13.2%)
$41.86B(-2.5%)
Sep 2020
-
$10.28B(+4.2%)
$42.91B(-5.3%)
Jun 2020
-
$9.86B(-2.2%)
$45.31B(-7.0%)
Mar 2020
-
$10.08B(-20.5%)
$48.72B(-5.9%)
Dec 2019
$41.17B(-23.3%)
$12.69B(+0.1%)
$51.75B(-2.4%)
Sep 2019
-
$12.68B(-4.4%)
$53.04B(-1.2%)
Jun 2019
-
$13.26B(+1.1%)
$53.66B(-0.4%)
Mar 2019
-
$13.12B(-6.1%)
$53.86B(+0.4%)
Dec 2018
$53.65B(+2.1%)
$13.98B(+5.1%)
$53.65B(+0.5%)
Sep 2018
-
$13.30B(-1.2%)
$53.37B(+0.2%)
Jun 2018
-
$13.47B(+4.3%)
$53.24B(+1.1%)
Mar 2018
-
$12.91B(-5.8%)
$52.67B(+0.2%)
Dec 2017
$52.55B(-0.5%)
$13.70B(+4.1%)
$52.55B(+0.1%)
Sep 2017
-
$13.17B(+2.1%)
$52.47B(+0.2%)
Jun 2017
-
$12.90B(+0.9%)
$52.35B(-0.5%)
Mar 2017
-
$12.78B(-6.2%)
$52.60B(-0.4%)
Dec 2016
$52.82B(+8.1%)
$13.63B(+4.5%)
$52.82B(-0.8%)
Sep 2016
-
$13.04B(-0.8%)
$53.24B(+1.8%)
Jun 2016
-
$13.15B(+1.1%)
$52.29B(+2.5%)
Mar 2016
-
$13.01B(-7.4%)
$50.99B(+4.4%)
Dec 2015
$48.85B(-1.5%)
$14.05B(+16.2%)
$48.85B(+1.9%)
Sep 2015
-
$12.09B(+2.0%)
$47.92B(-0.6%)
Jun 2015
-
$11.85B(+9.1%)
$48.20B(-1.9%)
Mar 2015
-
$10.86B(-17.2%)
$49.12B(-1.0%)
Dec 2014
$49.60B(-3.8%)
$13.12B(+6.1%)
$49.60B(-0.9%)
Sep 2014
-
$12.36B(-3.2%)
$50.05B(-0.6%)
Jun 2014
-
$12.77B(+12.5%)
$50.33B(-0.4%)
Mar 2014
-
$11.35B(-16.3%)
$50.53B(-4.1%)
Dec 2013
$51.58B(-5.6%)
$13.56B(+7.2%)
$52.67B(-2.8%)
Sep 2013
-
$12.64B(-2.5%)
$54.18B(-2.4%)
Jun 2013
-
$12.97B(-3.9%)
$55.52B(-3.6%)
Mar 2013
-
$13.50B(-10.4%)
$57.60B(-3.2%)
Dec 2012
$54.66B(-10.4%)
$15.07B(+7.8%)
$59.51B(-2.7%)
Sep 2012
-
$13.98B(-7.2%)
$61.18B(-5.0%)
Jun 2012
-
$15.06B(-2.3%)
$64.40B(-2.9%)
Mar 2012
-
$15.40B(-8.0%)
$66.33B(-1.6%)
Dec 2011
$61.03B(-9.0%)
$16.75B(-2.6%)
$67.42B(-1.2%)
Sep 2011
-
$17.19B(+1.2%)
$68.24B(+1.5%)
Jun 2011
-
$16.98B(+2.9%)
$67.22B(-0.5%)
Mar 2011
-
$16.50B(-6.0%)
$67.56B(-0.4%)
Dec 2010
$67.06B(+34.1%)
$17.56B(+8.6%)
$67.81B(+1.5%)
Sep 2010
-
$16.17B(-6.7%)
$66.78B(+7.3%)
Jun 2010
-
$17.33B(+3.4%)
$62.23B(+11.3%)
Mar 2010
-
$16.75B(+1.3%)
$55.89B(+11.8%)
Dec 2009
$50.01B(+3.5%)
$16.54B(+42.3%)
$50.01B(+9.1%)
Sep 2009
-
$11.62B(+5.8%)
$45.82B(-0.8%)
Jun 2009
-
$10.98B(+1.1%)
$46.17B(-2.4%)
Mar 2009
-
$10.87B(-12.0%)
$47.31B(-2.0%)
Dec 2008
$48.30B(-0.3%)
$12.35B(+3.1%)
$48.30B(-1.1%)
Sep 2008
-
$11.97B(-1.3%)
$48.82B(-0.0%)
Jun 2008
-
$12.13B(+2.4%)
$48.84B(+2.2%)
Mar 2008
-
$11.85B(-7.9%)
$47.79B(-1.3%)
Dec 2007
$48.43B(+0.1%)
$12.87B(+7.3%)
$48.42B(+0.6%)
Sep 2007
-
$11.99B(+8.2%)
$48.15B(-0.6%)
Jun 2007
-
$11.08B(-11.1%)
$48.44B(-1.3%)
Mar 2007
-
$12.47B(-1.0%)
$49.10B(+1.5%)
Dec 2006
$48.37B(+2.0%)
$12.60B(+2.6%)
$48.37B(-2.0%)
Sep 2006
-
$12.28B(+4.6%)
$49.36B(+2.1%)
Jun 2006
-
$11.74B(-0.1%)
$48.34B(-1.4%)
Mar 2006
-
$11.75B(-13.6%)
$49.03B(-2.7%)
Dec 2005
$47.41B(-9.7%)
$13.59B(+20.7%)
$50.37B(-2.6%)
Sep 2005
-
$11.26B(-9.4%)
$51.70B(-2.9%)
Jun 2005
-
$12.43B(-5.1%)
$53.27B(+0.3%)
Mar 2005
-
$13.09B(-12.3%)
$53.12B(+1.2%)
Dec 2004
$52.52B
$14.92B(+16.3%)
$52.52B(+1.5%)
Sep 2004
-
$12.83B(+4.5%)
$51.76B(+0.6%)
Jun 2004
-
$12.27B(-1.7%)
$51.43B(+4.6%)
DateAnnualQuarterlyTTM
Mar 2004
-
$12.49B(-11.9%)
$49.15B(+8.8%)
Dec 2003
$45.19B(+39.6%)
$14.17B(+13.3%)
$45.19B(+12.0%)
Sep 2003
-
$12.50B(+25.1%)
$40.35B(+10.3%)
Jun 2003
-
$9.99B(+17.2%)
$36.58B(+5.7%)
Mar 2003
-
$8.53B(-8.7%)
$34.62B(+0.3%)
Dec 2002
$32.37B(+0.9%)
$9.33B(+7.0%)
$34.51B(+0.9%)
Sep 2002
-
$8.72B(+8.6%)
$34.21B(+2.5%)
Jun 2002
-
$8.03B(-4.6%)
$33.38B(+1.1%)
Mar 2002
-
$8.42B(-6.8%)
$33.03B(+2.4%)
Dec 2001
$32.08B(+9.3%)
$9.03B(+14.3%)
$32.26B(+3.0%)
Sep 2001
-
$7.90B(+2.8%)
$31.33B(+2.3%)
Jun 2001
-
$7.69B(+0.5%)
$30.64B(+2.2%)
Mar 2001
-
$7.64B(-5.7%)
$30.00B(+12.5%)
Dec 2000
$29.36B(+80.9%)
$8.11B(+12.5%)
$26.67B(+15.5%)
Sep 2000
-
$7.21B(+2.3%)
$23.09B(+16.2%)
Jun 2000
-
$7.04B(+63.2%)
$19.88B(+19.6%)
Mar 2000
-
$4.32B(-4.8%)
$16.62B(+2.4%)
Dec 1999
$16.23B(+19.6%)
$4.53B(+13.6%)
$16.23B(+4.1%)
Sep 1999
-
$3.99B(+5.6%)
$15.59B(+4.4%)
Jun 1999
-
$3.78B(-3.8%)
$14.93B(+1.0%)
Mar 1999
-
$3.93B(+0.8%)
$14.79B(+4.1%)
Dec 1998
$13.57B(+8.3%)
$3.90B(+17.0%)
$14.20B(+6.2%)
Sep 1998
-
$3.33B(-8.3%)
$13.37B(+4.6%)
Jun 1998
-
$3.63B(+8.8%)
$12.79B(+6.0%)
Mar 1998
-
$3.34B(+8.7%)
$12.07B(+2.9%)
Dec 1997
$12.53B(+10.6%)
$3.07B(+11.8%)
$11.73B(+13.0%)
Sep 1997
-
$2.75B(-5.7%)
$10.38B(-0.5%)
Jun 1997
-
$2.91B(-3.0%)
$10.44B(+2.5%)
Mar 1997
-
$3.00B(+74.7%)
$10.18B(+3.2%)
Dec 1996
$11.33B(+12.6%)
$1.72B(-38.7%)
$9.86B(-9.4%)
Sep 1996
-
$2.80B(+5.3%)
$10.89B(+2.5%)
Jun 1996
-
$2.66B(-0.8%)
$10.63B(+1.7%)
Mar 1996
-
$2.68B(-2.3%)
$10.45B(+2.7%)
Dec 1995
$10.07B(+21.5%)
$2.74B(+8.1%)
$10.17B(+4.6%)
Sep 1995
-
$2.54B(+2.3%)
$9.72B(+5.0%)
Jun 1995
-
$2.48B(+3.3%)
$9.26B(+6.4%)
Mar 1995
-
$2.40B(+4.5%)
$8.70B(+5.1%)
Dec 1994
$8.28B(+10.7%)
$2.30B(+10.9%)
$8.28B(+3.9%)
Sep 1994
-
$2.07B(+7.9%)
$7.97B(+2.6%)
Jun 1994
-
$1.92B(-3.0%)
$7.77B(+2.3%)
Mar 1994
-
$1.98B(-0.3%)
$7.59B(+1.5%)
Dec 1993
$7.48B(+3.4%)
$1.99B(+6.2%)
$7.48B(+0.6%)
Sep 1993
-
$1.87B(+7.1%)
$7.44B(+0.6%)
Jun 1993
-
$1.75B(-6.4%)
$7.39B(+0.7%)
Mar 1993
-
$1.87B(-4.1%)
$7.34B(+1.5%)
Dec 1992
$7.23B(+4.0%)
$1.95B(+6.5%)
$7.23B(+1.4%)
Sep 1992
-
$1.83B(+7.9%)
$7.13B(+0.8%)
Jun 1992
-
$1.69B(-3.8%)
$7.08B(+0.9%)
Mar 1992
-
$1.76B(-4.8%)
$7.02B(+0.9%)
Dec 1991
$6.95B(+8.5%)
$1.85B(+4.4%)
$6.95B(+0.9%)
Sep 1991
-
$1.77B(+8.7%)
$6.89B(+1.9%)
Jun 1991
-
$1.63B(-3.8%)
$6.76B(+2.0%)
Mar 1991
-
$1.70B(-5.0%)
$6.62B(+3.3%)
Dec 1990
$6.41B(+13.0%)
$1.79B(+8.7%)
$6.41B(+4.8%)
Sep 1990
-
$1.64B(+9.8%)
$6.11B(+3.5%)
Jun 1990
-
$1.50B(+0.9%)
$5.91B(+3.4%)
Mar 1990
-
$1.48B(-0.8%)
$5.72B(+0.8%)
Dec 1989
$5.67B(+5.3%)
$1.49B(+3.9%)
$5.67B(+2.3%)
Sep 1989
-
$1.44B(+10.4%)
$5.55B(+1.0%)
Jun 1989
-
$1.30B(-9.3%)
$5.49B(-0.6%)
Mar 1989
-
$1.44B(+5.0%)
$5.52B(+2.6%)
Dec 1988
$5.39B(+9.5%)
$1.37B(-1.1%)
$5.39B(+1.8%)
Sep 1988
-
$1.38B(+3.5%)
$5.29B(+1.6%)
Jun 1988
-
$1.34B(+3.0%)
$5.21B(+2.1%)
Mar 1988
-
$1.30B(+1.8%)
$5.10B(+3.6%)
Dec 1987
$4.92B(+9.9%)
$1.28B(-1.7%)
$4.92B(+2.3%)
Sep 1987
-
$1.30B(+5.8%)
$4.81B(+2.9%)
Jun 1987
-
$1.23B(+9.6%)
$4.67B(+2.4%)
Mar 1987
-
$1.12B(-3.7%)
$4.56B(+2.0%)
Dec 1986
$4.48B(+11.2%)
$1.16B(-0.0%)
$4.48B(+2.4%)
Sep 1986
-
$1.16B(+4.0%)
$4.37B(+3.6%)
Jun 1986
-
$1.12B(+8.3%)
$4.22B(+2.8%)
Mar 1986
-
$1.03B(-2.4%)
$4.10B(+2.2%)
Dec 1985
$4.02B(+4.4%)
$1.06B(+4.5%)
$4.02B(+2.3%)
Sep 1985
-
$1.01B(+1.1%)
$3.93B(+0.8%)
Jun 1985
-
$1.00B(+5.9%)
$3.90B(+0.4%)
Mar 1985
-
$945.70M(-2.1%)
$3.88B(+0.7%)
Dec 1984
$3.85B(+2.8%)
$966.30M(-1.7%)
$3.85B(+33.5%)
Sep 1984
-
$982.70M(-0.3%)
$2.89B(+51.6%)
Jun 1984
-
$985.70M(+7.2%)
$1.91B(+107.2%)
Mar 1984
-
$919.80M
$919.80M
Dec 1983
$3.75B(+8.6%)
-
-
Dec 1982
$3.45B(+6.3%)
-
-
Dec 1981
$3.25B(+7.3%)
-
-
Dec 1980
$3.03B
-
-

FAQ

  • What is Pfizer Inc. annual revenue?
  • What is the all time high annual revenue for Pfizer Inc.?
  • What is Pfizer Inc. annual revenue year-on-year change?
  • What is Pfizer Inc. quarterly revenue?
  • What is the all time high quarterly revenue for Pfizer Inc.?
  • What is Pfizer Inc. quarterly revenue year-on-year change?
  • What is Pfizer Inc. TTM revenue?
  • What is the all time high TTM revenue for Pfizer Inc.?
  • What is Pfizer Inc. TTM revenue year-on-year change?

What is Pfizer Inc. annual revenue?

The current annual revenue of PFE is $63.63B

What is the all time high annual revenue for Pfizer Inc.?

Pfizer Inc. all-time high annual revenue is $100.33B

What is Pfizer Inc. annual revenue year-on-year change?

Over the past year, PFE annual revenue has changed by +$4.07B (+6.84%)

What is Pfizer Inc. quarterly revenue?

The current quarterly revenue of PFE is $14.65B

What is the all time high quarterly revenue for Pfizer Inc.?

Pfizer Inc. all-time high quarterly revenue is $27.74B

What is Pfizer Inc. quarterly revenue year-on-year change?

Over the past year, PFE quarterly revenue has changed by +$1.37B (+10.31%)

What is Pfizer Inc. TTM revenue?

The current TTM revenue of PFE is $63.83B

What is the all time high TTM revenue for Pfizer Inc.?

Pfizer Inc. all-time high TTM revenue is $101.28B

What is Pfizer Inc. TTM revenue year-on-year change?

Over the past year, PFE TTM revenue has changed by +$7.61B (+13.54%)
On this page